Indonesia and China Kexing Biotechnology Reached a 50 Million Doses of New Coronavirus Vaccine Supply Agreement

'The Straits Times' quoted foreign media sources on August 22 that Indonesia has signed a 50 million doses of new coronavirus vaccine supply agreement with China Kexing BioTechnology, which will allow this Chinese state-owned enterprise PT Bio Farma to produce locally.

Indonesian Foreign Minister Leitno tweeted on Friday that the Indonesian government is also seeking cooperation with Sinopharm Group.